معرفی
Bengt Lindberg is a Researcher at the Department of Paediatric Endocrinology, Faculty of Medicine, Lund University, affiliated with the Celiac Disease and Diabetes Unit and EXODIAB (Excellence of Diabetes Research in Sweden). His clinical role as a Physician in Paedritic Endocrinology focuses on diabetes, growth disorders, and autoimmune conditions in children.
His research centers on Diabetes Immunology, particularly GAD65 autoantibodies and epitope analysis in Type 1 Diabetes, with significant contributions to understanding HLA-DQ8 associations and diagnostic sensitivity. He investigates growth hormone disorders in pediatric populations, including refractoriness testing and therapeutic applications in genetic syndromes like Aarskog syndrome. Additional work explores asthma medication safety in children and the intersection of celiac disease with diabetes.
Analysis of his 35+ publications (2009-2023) reveals consistent focus on pediatric autoimmune endocrinology, emphasizing translational immunology techniques for diabetes diagnostics and therapeutic safety. His work bridges clinical pediatrics with molecular immunology, particularly in autoantibody conformational studies and growth hormone response mechanisms.
Dr. Lindberg actively collaborates through Lund University's Celiac Disease and Diabetes Unit and the national EXODIAB consortium, contributing to Sweden's diabetes research infrastructure. His fingerprint highlights expertise in Thyroid Antibodies, Glutamate Decarboxylase isoforms, and Insulin-dependent Diabetes pathophysiology, aligning with UN Sustainable Development Goal 3 (Good Health and Well-being).
